MindRank in Phase 3 trial with China's first AI -assisted new drug, cutting R&D costs by 60%
Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China's first artificial ...
Read the original at Yahoo Finance ↗
- Topics
- China & GeopoliticsHealthcare
- Mentions
- China
- Tracked via
- “chinese ai”
Same story, other outlets
- MindRank in Phase 3 trial with China's first AI -assisted new drug, cutting R&D costs by 60% South China Morning Post · Jan 04, 2026